News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

iBio, Inc. (IBPM) Release: Another Clinical Trial Commenced for a Product Based on iBioLaunch Technology



12/6/2010 11:19:21 AM

NEWARK, Del.--(BUSINESS WIRE)--iBio, Inc. (OTCBB: IBPM) announced today that the U.S. Food and Drug Administration (FDA) accepted another Investigational New Drug (IND) application filed for a product candidate made with the Company’s proprietary, transformative technology, the iBioLaunch™ technology platform.

Read at BioSpace.com


comments powered by Disqus
   
Influenza
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES